Lymphatic cancer
Malignant lymphoma, also known as "lymphoma", is a malignant tumor originating from lymph nodes or other lymphatic tissues. It is one of the ten most common malignant tumors in my country. This disease is more common in middle-aged and young people, and male patients are more common than female patients. This disease can be divided into two categories according to its cell components: Hodgkin's disease and non-Hodgkin's lymphoma. Its malignancy varies, and it is caused by the malignant proliferation of the lymph-tissue cell system, and mostly occurs in the lymph nodes.
-
Site of disease:
lymph -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Lymph node enlargement weight loss fever liver enlargement lymphatic metastasis -
Concurrent disease:
Related Drugs
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Sinopharm A-Think Pharmaceutical Co., Ltd.
Xinfumectin Injection
Indication: Used for malignant hydatidiform mole, choriocarcinoma, and malignant lymphoma.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Related Ingredients